These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2834759)

  • 1. The mechanism of action of antidepressant treatments: basic aspects.
    Green AR
    Pharmacopsychiatry; 1988 Jan; 21(1):3-5. PubMed ID: 2834759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.
    Lafaille F; Welner SA; Suranyi-Cadotte BE
    J Psychiatry Neurosci; 1991 Nov; 16(4):209-14. PubMed ID: 1664741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters.
    Green AR
    Neuropharmacology; 1987 Jul; 26(7B):815-22. PubMed ID: 2889156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
    Klimek V; Zak-Knapik J; Cannizzaro C
    Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of electroconvulsive shock on central serotonin1A receptor function].
    Hayakawa H; Yokota N; Yamawaki S
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):281-8. PubMed ID: 1701283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants. Current concepts of mode of action.
    Léonard BE
    Encephale; 1991; 17 Spec No 1():127-31. PubMed ID: 1677887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
    Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
    J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of antidepressant drugs and electroconvulsive shock on brain alpha 1-adrenoceptors following destruction of noradrenergic or serotonergic nerve terminals.
    Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1988; 40(4):393-400. PubMed ID: 2851781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments.
    Vetulani J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Pilc A
    Pol J Pharmacol Pharm; 1984; 36(2-3):231-48. PubMed ID: 6089158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidepressant drugs and beta-adrenergic receptors].
    Nomura S; Yamaoka K
    Yakubutsu Seishin Kodo; 1988 Sep; 8(3):437-41. PubMed ID: 2854932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
    Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
    Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.
    Kreiss DS; Lucki I
    J Pharmacol Exp Ther; 1995 Aug; 274(2):866-76. PubMed ID: 7636750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment.
    Vetulani J
    Pol J Pharmacol Pharm; 1984; 36(2-3):101-15. PubMed ID: 6089155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors.
    Frazer A; Lucki I
    Adv Biochem Psychopharmacol; 1982; 31():69-90. PubMed ID: 6282067
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological profile of binedaline, a new antidepressant drug.
    Morin D; Zini R; Urien S; Tillement JP
    J Pharmacol Exp Ther; 1989 Apr; 249(1):288-96. PubMed ID: 2540319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.